Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07094282 · ClinicalTrials.gov registry record · NA

Prospective Assessment of Integrative Therapies for Neuromusculoskeletal Pain (PAIN)

A NA study of Chronic Pain, sponsored by David Moss.

Recruiting
Registry status
NA
Development phase
125
Enrollment target
1
Study location

NCT07094282 is a NA study of Chronic Pain that is actively recruiting participants, run by David Moss. The registered enrollment target is 125 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07094282, a NA study of Chronic Pain, is actively recruiting participants, sponsored by David Moss.

RECRUITING
Registry status
NA
Development phase
125 participants
Enrollment target
1
Study location

Study Summary

With vast numbers of active-duty members restricted from their specific duties or deemed unfit for deployment because of low back pain, both the mission of the Department of Defense and overall military workflow can be significantly impacted. More than restriction from duty or being barred from deployment, studies have shown musculoskeletal conditions were among the top reasons for medical disability retirement in the Army and Marine Corps (Niebuhr; Sikorski). Given the significant time, money, and resources invested in training these members, each day of inactivity or disability detrimentally affects the execution of the military's mission. Therefore, precise diagnosis and effective treatment modalities are paramount to foster healing and reduce recovery time. From an operational standpoint, the United States Department of Defense (DoD) is specifically interested in using tailored integrative medicine modalities to manage chronic conditions encountered in the military health system. Not just chronic pain, but polytrauma and the triad of conditions it encompasses; traumatic brain injury and post-traumatic stress disorder combined with chronic pain (Madsen, Kim, Bedard). The DoD's goal is also to decrease opioid prescribing and the addiction and altered state associated with opioids. AT the Nellis Integrative Medicine Clinic, physicians, a chiropractor, and nurses are engaged in the treatment of patients. All personnel are trained in the various modalities available in the clinics. A variety of modalities are utilized in the clinic. This prospective study will evaluate the effectiveness of the many modalities used in the Integrative Medicine Clinic (such as acupuncture, myofascial therapies, microcurrent therapies, LASER therapy, extracorporeal shockwave therapy, and pulsed electromagnetic therapies). Most patients receive treatments using multiple modalities. DoD goals align with our experiences in the Integrative Medicine Clinic at Mike O'Callaghan Military Med

Conditions Studied

Interventions

  • OTHER Acupuncture
  • OTHER myofascial therapy
  • OTHER microcurrent therapy
  • OTHER LASER
  • OTHER extracorporeal shockwave therapy

Study Locations (1)

Nevada

  • Mike O'Callaghan Military Medical Center - Nellis Air Force Base

Trial Details

FieldValue
Enrollment Target 125 participants
Start Date 2025-08-04
Est. Completion 2028-07
Phase NA

Sponsor

David Moss

7 total trials

What the Registry Record Tells You About NCT07094282

The ClinicalTrials.gov registry entry for NCT07094282 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 125 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (84% lower). The listed sponsor is David Moss, which has 7 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Chronic Pain appearing as the primary indexed condition, and to 5 interventions - of which Acupuncture is the first listed.

NCT07094282 reports 1 study location spanning 1 distinct geographic area - top geographies include Nevada.

Frequently Asked Questions

What is clinical trial NCT07094282 about?

NCT07094282 is a clinical study titled "Prospective Assessment of Integrative Therapies for Neuromusculoskeletal Pain (PAIN)". With vast numbers of active-duty members restricted from their specific duties or deemed unfit for deployment because of low back pain, both the mission of the Department of Defense and overall military workflow can be significantly impacted. More than restriction from duty or being barred from depl...

What is the current status of trial NCT07094282?

This trial is currently recruiting. It is a NA study. The enrollment target is 125 participants. The study started on 2025-08-04. Estimated completion is 2028-07.

What conditions does trial NCT07094282 study?

This clinical trial studies the following conditions: Chronic Pain.

What interventions are being tested in trial NCT07094282?

The interventions under investigation include: Acupuncture (OTHER), myofascial therapy (OTHER), microcurrent therapy (OTHER), LASER (OTHER), extracorporeal shockwave therapy (OTHER).

Who is sponsoring clinical trial NCT07094282?

This trial is sponsored by David Moss, which has 7 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07094282 being conducted?

This trial has 1 study location across Nevada. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.